Fragile X Pre-mutation and Ovarian Function (R03) Modification 2

Submission Date: March 16, 2010


(Multiple Receipt Dates - See Link to Full Announcement for details.)

This funding opportunity announcement (FOA), issued by the National Institute of Child Health and Human Development, National Institutes of Health, solicits Small Research Grant (R03) applications from institutions/organizations that propose basic, clinical or translational research on the effects of the Fragile X pre-mutation on ovarian function, with a focus on premature ovarian failure or early menopause, in women and/or animal models.

Learn more.